2018
DOI: 10.5578/tt.67319
|View full text |Cite
|
Sign up to set email alerts
|

High serum YKL-40 level is associated with poor prognosis in patients with lung cancer

Abstract: High serum YKL-40 level is associated with poor prognosis in patients with lung cancer Introduction: YKL-40 is a glycoprotein that plays role in inflammation and malignant processes. High serum YKL-40 levels are associated with short survive in cancer and chronic obstructive pulmonary disease (COPD) is another reason to increase its' level. However, limited knowledges are known in YKL-40 along with lung cancer and COPD. Materials and Methods: One hundred patients were involved to study with lung cancer (84 men… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…Özdemir found that YKL-40 may be a predictor of tumour load and metastasis of prostate cancer [ 6 ]. It was reported that YKL-40 could promote the invasion and metastasis of NSCLC by inducing EMT [ 7 ]. The previous study also showed that the increased expression of YKL-40 could promote the invasion and migration of prostate cancer cells [ 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…Özdemir found that YKL-40 may be a predictor of tumour load and metastasis of prostate cancer [ 6 ]. It was reported that YKL-40 could promote the invasion and metastasis of NSCLC by inducing EMT [ 7 ]. The previous study also showed that the increased expression of YKL-40 could promote the invasion and migration of prostate cancer cells [ 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…Chronic obstructive pulmonary disease (COPD) is a progressive lung disorder characterized by a persistent airflow limitation and chronic inflammation. Previous studies investigating the correlation between CHI3L1 (YKL40) expression levels and COPD progression have reported elevated levels of CHI3L1 (YKL40) in the blood, sputum, and lung tissue of individuals with COPD compared to healthy individuals or those with other respiratory conditions [ 30 , 31 , 32 , 33 , 34 ]. Moreover, Matsuura et al also reported that higher CHI3L1 (YKL40) levels were associated with more severe COPD phenotypes, including a decline in lung function and emphysema severity, and an increased risk of acute exacerbations [ 35 ].…”
Section: Pathological Roles Of Chi3l1 (Ykl40)mentioning
confidence: 99%